People: Rochester Medical Corp (ROCM.W)
ROCM.W on CBOE When Trading NASDAQ Global Select Market
14.80USD
17 Jun 2013
14.80USD
17 Jun 2013
Price Change (% chg)
$0.07 (+0.48%)
$0.07 (+0.48%)
Prev Close
$14.73
$14.73
Open
$14.80
$14.80
Day's High
$14.80
$14.80
Day's Low
$14.80
$14.80
Volume
100
100
Avg. Vol
97
97
52-wk High
$14.89
$14.89
52-wk Low
$9.29
$9.29
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Anthony Conway |
68 | 2008 | Chairman of the Board, President, Chief Executive Officer |
David Jonas |
48 | 2008 | Chief Financial Officer, Treasurer, Secretary, Director |
James Carper |
61 | 2011 | Vice President - U.S. Sales and Marketing |
Robert Anglin |
45 | 2008 | Vice President - Quality & Regulatory |
Philip Conway |
55 | 1999 | Vice President - Production Technologies |
Sarah Grinde |
39 | 2012 | Vice President - Development & Research |
Martyn Sholtis |
53 | 2001 | Corporate Vice President |
Darnell Boehm |
64 | 1995 | Independent Director |
Peter Shepard |
67 | 2012 | Independent Director |
Biographies
| Name | Description |
|---|---|
Anthony Conway |
Mr. Anthony J. Conway is Chairman of the Board, President, Chief Executive Officer of Rochester Medical Corp. He was one of the company's founders, has served as the company's Chairman of the Board, Chief Executive Officer and President since May 1988. In addition to his duties as Chief Executive Officer, Mr. Conway actively contributes to the company's research and development and design activities. From 1979 to March 1988, he was President, Secretary and Treasurer of Arcon Corporation, a company that he co-founded with Philip J. Conway to develop, manufacture and sell latex-based male external catheters and related medical devices. Prior to founding Arcon, Mr. Conway worked for twelve years for International Business Machines Corporation in various research and development capacities. Mr. Conway is one of the named inventors on numerous patent applications that have been assigned to the company, of which to date over 20 resulted in issued U.S. patents and 32 have resulted in issued foreign patents. |
David Jonas |
Mr. David A. Jonas is Chief Financial Officer, Treasurer, Secretary, Director of Rochester Medical Corp. He serves as the company's Chief Financial Officer, Treasurer and as the company's Secretary. Mr. Jonas has also served as a member of the company's Board of Directors since November 2008. From June 1, 1998 until May 2001, Mr. Jonas served as the company's Controller. From August 1999 until October 2001, Mr. Jonas served as the company's Director of Operations and had principal responsibility for the company's operational activities. Since November 2000, Mr. Jonas has had principal responsibility for the company's financial activities. Prior to joining the company, Mr. Jonas was employed in various financial, financial management and operational management positions with Polaris Industries, Inc. from January 1989 to June 1998. Mr. Jonas holds a BS degree in Accounting from the University of Minnesota and is a certified public accountant currently under a "non-active" status. |
James Carper |
Mr. James M. Carper is Vice President - U.S. Sales and Marketing of Rochester Medical Corp. He is responsible for all direct sales activity in the United States. Mr. Carper joined the Company in 1994 as a Regional Sales Manager and was promoted in 1996 to Director of Marketing, a position he held until September 2000. Mr. Carper ran his own marketing agency from 2000 to 2007 before rejoining the Compan as the Marketing Director. Prior to Rochester Medical, he served as the Marketing Manager for urological products with Sherwood Medical. |
Robert Anglin |
Mr. Robert M. Anglin is Vice President - Quality & Regulatory of Rochester Medical Corp. He serves as the company's Vice President of Quality and Regulatory. From December 2003 until November 2008, Mr. Anglin served as the company's Director of Quality and Regulatory with principal responsibility for the company's quality and regulatory compliance activities. From September 2000 until December 2003, Mr. Anglin served as Company's Director of Quality with principal responsibility for the company's quality management system. From June 1991 until September 2000, Mr. Anglin served in various operational, quality, and product development activities. Mr. Anglin holds a BS degree in Operations Management from Winona State University and holds various professional certifications from the Regulatory Affairs Professionals Society, American Society for Quality, and the APICS Association for Operations Management. |
Philip Conway |
Mr. Philip J. Conway is Vice President - Production Technologies of Rochester Medical Corp. He is one of the founders. From 1988 to July 1999, Mr. Conway served as the Vice President of Operations. Mr. Conway is responsible for plant design as well as new product and production processes, research, design and development activities. Since November 2001, he has had principal responsibility for the operational activities. From 1979 to March 1988, Mr. Conway served as Plant and Production Manager of Arcon Corporation. Prior to joining Arcon, Mr. Conway was employed in a production supervisory capacity by AFC Corp., a manufacturer and fabricator of fiberglass, plastics and other composite materials. He is one of the named inventors on numerous patent applications that have been assigned to the Company, of which to date 20 have resulted in issued U.S. patents and 32 have resulted in issued foreign patents. |
Sarah Grinde |
Ms. Sarah L. Grinde serves as Vice President - Development & Research of Rochester Medical Corp. She joined the company in November 2006 and serves as the company's Vice President of Development & Research. Ms. Grinde is responsible for project management, product development and business activities related to the strategic deployment and introduction of new technologies and products on a global basis. From 2006 to November 2011, Ms. Grinde served in a variety of marketing roles specifically focused on development and introduction of new products. In December 2011, Ms. Grinde was promoted to Project Development Manager responsible for project management as well as invention and development of new technologies, before assuming her current position in November 2012. Ms. Grinde holds a BS degree in Business Administration from Mayville State University. |
Martyn Sholtis |
Mr. Martyn R. Sholtis is Corporate Vice President of Rochester Medical Corp. He joined the company in April 1992 and serves as the company's Corporate Vice President. Mr. Sholtis is responsible for corporate business development activities, private label sales and also leads the company's international sales team. From 1985 to 1992, Mr. Sholtis was employed by Sherwood Medical, a company that manufactured and sold a variety of disposable medical products including urological catheters, most recently as Regional Sales Manager for the Nursing Care Division. |
Darnell Boehm |
Mr. Darnell L. Boehm is Independent Director of Rochester Medical Corp. Since 1986, Mr. Boehm has served as a Director of Aetrium, Inc. (“Aetrium”), a manufacturer of electromechanical equipment for handling and testing semiconductors, and also serves on its Audit Committee and Compensation Committee. From 1986 to 2000, Mr. Boehm also served as the Chief Financial Officer and Secretary of Aetrium. From August 1999 to January 2002, Mr. Boehm served as a Director of ALPNET, Inc., a supplier of multilingual information services including language translation, product localization and other services. He is also the principal of Darnell L. Boehm & Associates, a management consulting firm. He is a Certified Public Accountant. |
Peter Shepard |
Mr. Peter H. Shepard is Independent Director of Rochester Medical Corp. Mr. Shepard volunteers his time at Santa Barbara Cottage Hospital where he is Chairman of the Auxiliary Ambassador Committee. From 1976 to August 2004, Mr. Shepard held a number of sales & marketing and business development positions in the Urology and Urogynecology division of Mentor Corporation, a supplier of surgical aesthetics products that is now part of Johnson & Johnson, retiring as Senior Vice-President Global Sales & Marketing and Business Development. Mr. Shepard received his bachelor’s degree from the University of the Pacific following a four-year term in the Navy as a Hospital Corpsman specializing as a surgical scrub technician. Mr. Shepard is a member of the Society of Urologic Nurses and Associates, the Association of Rehabilitation Nurses and the International Continence Society. During his career he also held positions on the Board of Trustees for the Association of Rehabilitation Nurses, on the Industry Council for the American Urological Association, and as Industry Council Chairperson for the National Association for Continence. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Anthony Conway |
808,418 |
David Jonas |
471,568 |
James Carper |
381,758 |
Robert Anglin |
-- |
Philip Conway |
405,546 |
Sarah Grinde |
-- |
Martyn Sholtis |
440,082 |
Darnell Boehm |
-- |
Peter Shepard |
-- |
As Of 29 Sep 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Anthony Conway |
346,000 | 1,170,785 |
David Jonas |
304,000 | 1,330,301 |
James Carper |
0 | 0 |
Robert Anglin |
0 | 0 |
Philip Conway |
280,000 | 1,162,374 |
Sarah Grinde |
0 | 0 |
Martyn Sholtis |
183,000 | 874,114 |
Darnell Boehm |
0 | 0 |
Peter Shepard |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
JONAS DAVID A |
10,000 | $0.00 |
GRINDE SARAH L |
10,000 | $0.00 |
ANGLIN ROBERT M |
4,000 | $4.63 |
SHOLTIS MARTYN R |
15,000 | $14.75 |
SHOLTIS MARTYN R |
3,000 | $4.70 |
SHOLTIS MARTYN R |
12,000 | $4.63 |
ANGLIN ROBERT M |
4,000 | $14.70 |
SHOLTIS MARTYN R |
1,500 | $14.80 |
CONWAY PHILIP J |
13,000 | $4.70 |
CONWAY PHILIP J |
12,000 | $4.63 |
CONWAY PHILIP J |
25,000 | $11.64 |
KRAMP RICHARD W |
12,281 | $0.00 |
BOEHM DARNELL L |
4,281 | $0.00 |
SHEPARD PETER H |
4,281 | $0.00 |
SMITH BENSON F |
4,000 | $4.13 |
SMITH BENSON F |
10,000 | $4.63 |
SMITH BENSON F |
20,000 | $5.70 |
SMITH BENSON F |
10,000 | $4.70 |
GRINDE SARAH L |
500 | $9.90 |
CONWAY ANTHONY J |
16,000 | $9.90 |
CONWAY ANTHONY J |
16,000 | $4.13 |
JONAS DAVID A |
10,000 | $4.13 |
SHOLTIS MARTYN R |
9,700 | $10.91 |
SHOLTIS MARTYN R |
9,700 | $4.13 |
JONAS DAVID A |
10,000 | $10.81 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
